Navigation Links
FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
Date:11/20/2008

ROCKVILLE, Md., Nov. 20 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, reported today that the FDA has accepted Vanda's resubmission of the iloperidone New Drug Application (NDA).

Vanda's resubmission was a Complete Response to the not approvable action letter that the company received on July 25, 2008. The FDA has indicated that it has accepted the Complete Response for review and has set a new target action date of May 6, 2009.

ABOUT VANDA PHARMACEUTICALS INC.:

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Various statements in this release are "forward-looking statements" under the securities laws. Words such as, but not limited to, "believe," "expect," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," and "could," and similar expressions or words, identify forward-looking statements. Forward-looking statements are based upon current expectations that involve risks, changes in circumstances, assumptions and uncertainties. Vanda is at an early stage of development and may not ever have any products that generate significant revenue. Important factors that could cause actual results to differ materially from those reflected in the company's forward-looking statements include, among others: delays in the completion of Vanda's clinical trials; a failure of Vand
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
2. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
3. American Stock Exchange Accepts Encisions Plan to Regain Compliance
4. Governor Rendell Accepts National Health Care Reform Pioneer Award
5. FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
6. Lieutenant Governor Catherine Baker Knoll Accepts Women in Government Presidential Leadership Award
7. ev3 Inc. Accepts Resignation of Dr. John Simpson
8. Mike Huckabee Accepts Values Voter Presidential Debate
9. AMEX Accepts Lorus Plan to Meet AMEXs Continued Listing Standards
10. Partnering With MyPyramid: NUTRIKIDS Accepts the Challenge to Help Families Step Up to Healthier Living
11. FDA Accepts Gentas NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic Leukemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009).... Centers for Disease Control and Prevention estim...d States are infected with HIV/AIDS. New research ...ny of those infected are minorities and do not hav...national strategy to facilitate education and prev...ons. , The research, which analyzed 90,000 HIV p...
(Date:11/30/2009)... Author of "My Two-Year Old E... children who love to eat everything. , ... have a picky eater in your house? Do you find yo...Three new short online videos – one focusing... the third on answers for real-life parents’...
(Date:11/30/2009)... , ENGLEWOOD, Colo., Nov. 30 ...entation discussing what "culture of safety" means...osium presentation, "Creating a Culture of Safety...professionals discussing their experiences with cu...of safety in pharmacy and the role of technology i...
(Date:11/30/2009)..., KALAMAZOO, Mich., Nov. 30 /PRNewswire-FirstCall...unced a definitive agreement to acquire privately... leader in the reprocessing and remanufacturing of...s of the agreement, Stryker will acquire Ascent He... transaction. The closing is conditioned on the ex...
(Date:11/30/2009)... N.C. Finding and treating a tumor without distur...the most effective therapies can be invasive and h...enter have devised a way they might deliver the ri...ules, called aptamers, which specifically bind to ...l of aptamers in a rodent with liver cancer until ...
Breaking Medicine News(10 mins):Health News:Research highlights need for national HIV strategy 2Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 2Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 3Health News:First live targeting of tumors with RNA-based technology 2Health News:First live targeting of tumors with RNA-based technology 3
...ss Scripts, Inc. (Nasdaq: ESRX ) announced that ...ealth Care Conference on May 19, 2009 at 10:10 a.m... , This presentation will also be broadcast via th...ws Media Player is needed to listen to the Webcast...
... 13 /PRNewswire-Asia/ -- Winner Medical Group Inc....the "Company"), today,reported unaudited financial...9. The Company,s results are detailed in its form ...eased by 15.31% over the second quarter of, ...
...vity of Cystathionase is reduced in rodent models ...and impaired generation of hydrogen sulphide, two ... and increased intrahepatic resistance. , In the p...ligand to carbon tetrachloride treated mice protec...
...ing a hallmark of hereditary hemochromatosis , is ... or non-alcoholic steatohepatitis and non-alcoholi...has investigated the link between ferritin and ste...present a risk factor for steatosis and clinical r...
...n pump inhibitor which powerfully suppresses gastr...ronic use in gastroesophageal reflux disease. Lans... unresponsive to conventional medication as a symp...e is impossible. Discontinuation of lansoprazole r...
...ial Day Is Declared "Don,t Fry Day" to Encourage S... As millions of Americans prepare to enjoy the gr...uncil on Skin Cancer Prevention reminds everyone t... rise significantly, at a rate faster than any of ...
Other Medicine News:Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 2Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 3Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 4Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 5Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 6Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 7Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 8Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 9Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 10Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 11Health News:Farnesoid X receptor regulates cystathionase 2Health News:Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole? 2Health News:The National Council on Skin Cancer Prevention Encourages Everyone to Protect Your Skin Today and Every Day 2Health News:The National Council on Skin Cancer Prevention Encourages Everyone to Protect Your Skin Today and Every Day 3
(Date:11/30/2009)...ewswire/ -- StemCyte, Inc. concluded an exclusive ...mia Sinica, the National Laboratory of Taiwan, for...erty (IP) related to the treatment of Chronic Stro...red by a team led by Professor John Lin, MD, PhD a...urrently the exclusive collaborator with StemCyte ...
(Date:11/30/2009)...30 eHealthSource.com launched the ...o products approved for Flexible Spending Account ...ite is also the first to exclusively carry value-b...s up to 75 percent on everyday healthcare needs. ...are headaches - high costs and complexity," says e...
(Date:11/30/2009)...30 Health Robotics today announced...s and product specifications,for a new and revolut...ition", a new key component of its i.v. Room of th... (Booth # 114). , "I look forward to see ...s blueprints and to find out if TPNstation appears...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3eHealthSource.com Launches Online Shopping Site Dedicated to Over-the Counter Medications Approved for FSA/HSA Claims 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 2Health Robotics to Unveil TPNstation(TM) at the American Society of Health-System Pharmacists on December 7th 3Landmark project to map genomics of complex ant systems 9188 1Landmark project to map genomics of complex ant systems 9188 2European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 1European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 2Pioneer of Digital Place Based Media Joins World 26apos 3Bs Leading Blood Pressure and Health Kiosk Manufacturer 51199 1Pioneer of Digital Place Based Media Joins World 26apos 3Bs Leading Blood Pressure and Health Kiosk Manufacturer 51199 2
...BANE, Calif.--(BUSINESS WIRE)--Jul 2, 2007 - Terci...y management will make an,investment community pre...rowth Opportunities Conference at the Mandarin Ori...7 at 4:00 p.m. Eastern,time (1:00 p.m. Pacific tim...ill be available,via the Internet by visiting the ...
...RIDGE, Mass.--(BUSINESS WIRE)--Jul 2, 2007 - ViaCe...D. Beer, President and,Chief Executive Officer of ...tivities and product pipeline at the C.E. Unterber... on Tuesday, July,10, 2007 at 3:00 p.m. at the Man... webcast of the presentation will be available on,...
Other Medicine Technology:
...umin Cobalt Binding (ACB®) Test is a clinical ...umin (IMA®) by measuring the cobalt binding ca... identified in the early 1990s, IMA is produced wh...mic tissue in the heart. During ischemia, the N-te...
...t menu includes kits that quantitatively measure t...d lipoprotein (a). An elevated serum or plasma hom... and independent risk factor for cardiovascular di...have associated elevated levels of Lp(a) with incr...
...t menu includes kits that quantitatively measure t...d lipoprotein (a). An elevated serum or plasma hom... and independent risk factor for cardiovascular di...have associated elevated levels of Lp(a) with incr...
...ss Medical Professional Diagnostics is a leading p...nsive IFA and DFA test menu that includes kits for... as well as miscellaneous conjugates and component...ortment of substrates and kit sizes to choose from...
Medicine Products: